Everything by Chris.

Technology

Ambarella Earnings Aren’t Enough for Investors

Jun 6, 2017 Investing

Tuesday’s Biggest Winners and Losers in the S&P 500

Jun 6, 2017 Health and Healthcare

Celldex Therapeutics Sinks Following ASCO Results

Jun 6, 2017 Technology

Merrill Lynch’s Top Picks in Robot and AI Stocks

Jun 6, 2017 Investing

Betting on Millennials: Merrill Lynch’s Best Thematic Investment Ideas

Jun 6, 2017 Health and Healthcare

Why Albany Molecular Is Actually Getting a Very Good Premium

Jun 6, 2017 Health and Healthcare

Athenex Announces Potential Price Range for IPO

Jun 6, 2017 Retail

Why Conn’s Bottom-Line Beat Was Not Enough for Investors

Jun 6, 2017 Investing

Monday’s Biggest Winners and Losers in the S&P 500

Jun 5, 2017 Health and Healthcare

Juno Therapeutics Sinks Following ASCO Update

Jun 5, 2017 Investing

Merrill Lynch Gets More Bullish on 8 Top Stocks

Jun 5, 2017 Media

Why Yelp Was Upgraded and Snap Was Downgraded

Jun 5, 2017 Housing

Why Forestar Shares Are Making a Run

Jun 5, 2017 Health and Healthcare

Aileron Therapeutics Gears Up for IPO

Jun 5, 2017 Health and Healthcare

7 ASCO Stocks Moving on Cancer Study News (Updated)

Jun 5, 2017 Health and Healthcare

What Analysts Have to Say About Walgreens Ahead of the Merger Deadline

Jun 3, 2017 Retail

After Earnings, Are Analysts Kicking Michael Kors While It’s Down?

Jun 3, 2017 Health and Healthcare

15 Companies Bracing for Big ASCO Reactions

Jun 2, 2017 Technology

Broadcom Wins Big on Q2 Earnings

Jun 2, 2017 Companies and Brands

Why Lululemon Is Rallying

Jun 2, 2017